Gene · 9656
Papers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Transcriptome Profiling of Peripheral Blood Mononuclear Cells from Patients with Sepsis. | Int J Med Sci | 2020 | 32922168 | PubTator, text mining | PubMed |
| Extracellular matrix stiffness determines DNA repair efficiency and cellular sensitivity to genotoxic agents. | Sci Adv | 2020 | 32917705 | PubTator, text mining | PubMed |
| En Guard! The Interactions between Adenoviruses and the DNA Damage Response. | Viruses | 2020 | 32906746 | PubTator, text mining | PubMed |
| SRSF6 regulates alternative splicing of genes involved in DNA damage response and DNA repair in HeLa cells. | Oncol Rep | 2020 | 32901876 | PubTator, text mining | PubMed |
| Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks. | Int J Mol Sci | 2020 | 32899704 | PubTator, text mining | PubMed |
| H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival. | J Clin Med | 2020 | 32887437 | PubTator, text mining | PubMed |
| LDNFSGB: prediction of long non-coding rna and disease association using network feature similarity and gradient boosting. | BMC Bioinformatics | 2020 | 32883200 | PubTator, text mining | PubMed |
| Synergistic Interactions of 5-Fluorouracil with Inhibitors of Protein Kinase CK2 Correlate with p38 MAPK Activation and FAK Inhibition in the Triple-Negative Breast Cancer Cell Line. | Int J Mol Sci | 2020 | 32872257 | PubTator, text mining | PubMed |
| Roles for MDC1 in cancer development and treatment. | DNA Repair (Amst) | 2020 | 32866776 | PubTator, text mining | PubMed |
| Inside the hypoxic tumour: reprogramming of the DDR and radioresistance. | Cell Death Discov | 2020 | 32864165 | PubTator, text mining | PubMed |
| Recent advances in the nucleolar responses to DNA double-strand breaks. | Nucleic Acids Res | 2020 | 32857853 | PubTator, text mining | PubMed |
| USP7 Is a Master Regulator of Genome Stability. | Front Cell Dev Biol | 2020 | 32850836 | PubTator, text mining | PubMed |
| The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer. | Front Oncol | 2020 | 32850380 | PubTator, text mining | PubMed |
| A Framework of All Discovered Immunological Pathways and Their Roles for Four Specific Types of Pathogens and Hypersensitivities. | Front Immunol | 2020 | 32849663 | PubTator, text mining | PubMed |
| Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead. | Front Immunol | 2020 | 32849502 | PubTator, text mining | PubMed |
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours. | Br J Cancer | 2020 | 32839491 | PubTator, text mining | PubMed |
| Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem/progenitor cells. | Oncotarget | 2020 | 32821342 | PubTator, text mining | PubMed |
| Yeast ATM and ATR kinases use different mechanisms to spread histone H2A phosphorylation around a DNA double-strand break. | Proc Natl Acad Sci U S A | 2020 | 32817543 | PubTator, text mining | PubMed |
| Targeting UHRF1-dependent DNA repair selectively sensitizes KRAS mutant lung cancer to chemotherapy. | Cancer Lett | 2020 | 32814087 | PubTator, text mining | PubMed |
| The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression. | Aging (Albany NY) | 2020 | 32805721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9656/papers?page=43